The current BCLI market cap is 28.86M. The company's latest EPS is USD and P/E is N/A.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -6.84M | -4.92M | -5.15M | -5.45M | -6.04M |
Net Income | -6.86M | -5.02M | -5.06M | -5.33M | -1.23M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -14.06M | -23M | -31.68M | -24.54M | -24.82M |
Net Income | -13.95M | -23.25M | -31.81M | -24.46M | -24.28M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 13.25M | 8.45M | 7.87M | 5.75M | 5.68M |
Total Liabilities | 11.87M | 11.47M | 12.71M | 9.63M | 8.26M |
Total Equity | 1.39M | -3.02M | -4.84M | -3.88M | -2.58M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 11.23M | 6.53M | 51.26M | 29.28M | 8.45M |
Total Liabilities | 6.21M | 18.76M | 15.8M | 9.94M | 11.47M |
Total Equity | 5.02M | -12.22M | 35.46M | 19.34M | -3.02M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -14.67M | -19.32M | -3.99M | -10.76M | -17.17M |
Investing | -40k | 998k | 2.01M | 2.01M | 2M |
Financing | N/A | 238k | 3.23M | 8.53M | 15.63M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -12.39M | -11.25M | -35.19M | -26.27M | -19.32M |
Investing | -1.22M | 5.62M | -4.45M | 323k | 998k |
Financing | 12.07M | 5.23M | 76.94M | 6.97M | 238k |
Market Cap | 28.86M |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 48.98M |
Average Volume (1 week) | 2.21M |
Average Volume (1 Month) | 1.18M |
52 Week Change | -65.75% |
52 Week High | 3.46 |
52 Week Low | 0.134 |
Spread (Intraday) | 0.01 (1.7%) |
Company Name | Brainstorm Cell Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.brainstorm-cell.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.